GURUFOCUS.COM » STOCK LIST » Technology » Semiconductors » GemVax & KAEL Co Ltd (XKRX:082270) » Definitions » Gross Margin %

GemVax & KAEL Co (XKRX:082270) Gross Margin % : 26.71% (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is GemVax & KAEL Co Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. GemVax & KAEL Co's Gross Profit for the three months ended in Dec. 2023 was ₩4,891 Mil. GemVax & KAEL Co's Revenue for the three months ended in Dec. 2023 was ₩18,313 Mil. Therefore, GemVax & KAEL Co's Gross Margin % for the quarter that ended in Dec. 2023 was 26.71%.

Warning Sign:

GemVax & KAEL Co Ltd gross margin has been in long-term decline. The average rate of decline per year is -2.4%.


The historical rank and industry rank for GemVax & KAEL Co's Gross Margin % or its related term are showing as below:

XKRX:082270' s Gross Margin % Range Over the Past 10 Years
Min: 22.08   Med: 33.27   Max: 38.91
Current: 36.07


During the past 13 years, the highest Gross Margin % of GemVax & KAEL Co was 38.91%. The lowest was 22.08%. And the median was 33.27%.

XKRX:082270's Gross Margin % is ranked better than
64.31% of 975 companies
in the Semiconductors industry
Industry Median: 28.54 vs XKRX:082270: 36.07

GemVax & KAEL Co had a gross margin of 26.71% for the quarter that ended in Dec. 2023 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for GemVax & KAEL Co was -2.40% per year.


GemVax & KAEL Co Gross Margin % Historical Data

The historical data trend for GemVax & KAEL Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GemVax & KAEL Co Gross Margin % Chart

GemVax & KAEL Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.33 38.91 31.27 28.84 36.07

GemVax & KAEL Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.84 20.11 59.05 25.45 26.71

Competitive Comparison of GemVax & KAEL Co's Gross Margin %

For the Semiconductor Equipment & Materials subindustry, GemVax & KAEL Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GemVax & KAEL Co's Gross Margin % Distribution in the Semiconductors Industry

For the Semiconductors industry and Technology sector, GemVax & KAEL Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where GemVax & KAEL Co's Gross Margin % falls into.



GemVax & KAEL Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

GemVax & KAEL Co's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=26048.3 / 72208.573
=(Revenue - Cost of Goods Sold) / Revenue
=(72208.573 - 46160.225) / 72208.573
=36.07 %

GemVax & KAEL Co's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=4891 / 18312.934
=(Revenue - Cost of Goods Sold) / Revenue
=(18312.934 - 13421.908) / 18312.934
=26.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


GemVax & KAEL Co  (XKRX:082270) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

GemVax & KAEL Co had a gross margin of 26.71% for the quarter that ended in Dec. 2023 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


GemVax & KAEL Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of GemVax & KAEL Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


GemVax & KAEL Co (XKRX:082270) Business Description

Traded in Other Exchanges
N/A
Address
894, Tamnip-Dong, Yuseong-Gu, Daejeon, KOR, 305-510
GemVax & KAEL Co Ltd is primarily engaged in manufacturing and commercializing of coating resin and filters for semiconductors and panel display production. It offers chemical air filter, scrubber resin, and devices for preventing environmental contamination and eliminating harmful gas, for semiconductor and display industry. Its other business operations include research and development of anti-cancer immunotherapeutic and peptide drugs. The company organizes its business operations into three distinct segments: Environmental Pollution Control Business, IT Business, Bio-business. The company's product portfolio consists fundamental products, semiconductor, and display, equipment and system, fire evacuation mask 5aver.

GemVax & KAEL Co (XKRX:082270) Headlines

No Headlines